British Journal of Haematology

Acute myeloblastic leukaemia with differentiation to myeloblasts and mast cell blasts
pp. 991-991(1)
Author: Varma N.

Heparin-induced skin necrosis
pp. 992-992(1)
Author: Arnold J.

CHRONIC MYELOGENOUS LEUKAEMIA
pp. 993-1009(17)
Author: Lee S.J.

Pure red cell aplasia
pp. 1010-1022(13)
Authors: Fisch P.; Handgretinger R.; Schaefer H-E.

Historical aspects of chronic lymphocytic leukaemia
pp. 1023-1034(12)
Author: Hamblin T.

Multiple myeloma: an odyssey of discovery
pp. 1035-1044(10)
Author: Kyle R.A.

Haematologists' approaches to the management of adolescents and young adults with acute leukaemia
pp. 1045-1050(6)
Authors: Benjamin S.; Kroll M.E.; Cartwright R.A.; Clough J.V.; Gorst D.W.; Proctor S.J.; Ross J.R.Y.; Taylor P.R.A.; Wheatley K.; Whittaker J.A.; Stiller C.A.

Cytogenetically cryptic AML1–ETO and CBF–MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia
pp. 1051-1056(6)
Authors: Rowe D.; Cotterill S.J.; Ross F.M.; Bunyan D.J.; Vickers S.J.; Bryon J.; McMullan D.J.; Griffiths M.J.; Reilly J.T.; Vandenberghe E.A.; Wilson G.; Watmore A.E.; Bown N.P.

Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells
pp. 1057-1064(8)
Authors: Xie Y.; de Winter J.P.; Waisfisz Q.; Nieuwint A.W.M.; Scheper R.J.; Arwert F.; Hoatlin M.E.; Ossenkoppele G.J.; Schuurhuis G-J.; Joenje H.

Myeloperoxidase gene expression in non-infant pro-B acute lymphoblastic leukaemia with or without ALL1/AF4 transcript
pp. 1065-1070(6)
Authors: Serrano J.; Lo Coco F.; Sprovieri T.; Elia L.; Vitale A.; Gregorj C.; Tafuri A.; Sánchez J.; Román J.; Torres A.; Cimino G.

Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value
pp. 1071-1079(9)
Authors: Codrington R.; O'connor H.E.; Jalali G.R.; Carrara P.; Papaioannou M.; Hart S.M.; Hoffbrand A.V.; Potter M.; Prentice H.G.; Harrison C.J.; Foroni L.

Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia
pp. 1080-1086(7)
Authors: de Haas V.; Oosten L.; Dee R.; Verhagen O.J.H.M.; Kroes W.; van den Berg H.; van der Schoot C.E.

Antisense oligonucleotides complementary to immunoglobulin sequences of BCL-2/immunoglobulin fusion transcript induce apoptosis of t(14;18) lymphoma cells
pp. 1087-1092(6)
Authors: Smith M.R.; Xie T.; Zhou Z-Z.; Joshi I.

Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II
pp. 1093-1102(10)
Authors: Fleischhack G.; Kambeck I.; Cipic D.; Hasan C.; Bode U.

Molecular remission without blood product support using all-trans retinoic acid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia
pp. 1103-1105(3)
Authors: Kennedy G.A.; Marlton P.; Cobcroft R.; Gill D.

BCL10 deletions in haematological malignancies: a cloning artefact?
pp. 1106-1108(3)
Authors: Duke V.; Kapoor A.; Gricks C.; Melo J.; Foroni L.

Are aberrant BCR–ABL transcripts more common than previously thought?
pp. 1109-1111(3)
Authors: Wilson G.A.; Vandenberghe E.A.; Pollitt R.C.; Rees D.C.; Goodeve A.C.; Peake I.R.; Reilly J.T.

Novel association of haemophagocytic syndrome with Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma
pp. 1112-1115(4)
Authors: Pastore R.D.; Chadburn A.; Kripas C.; Schattner E.J.

Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13
pp. 1116-1117(2)
Authors: Avet-Loiseau H.; Daviet A.; Saunier S.; Bataille on behalf of the Intergroupe Francophone du Myélome R.

Bone sialoprotein mRNA and protein expression in human multiple myeloma cell lines and patients
pp. 1118-1121(4)
Authors: Bellahcène A.; Van Riet I.; de Greef C.; Antoine N.; Young M.F.; Van Camp B.; Castronovo V.

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study
pp. 1122-1129(8)
Authors: Chopra R.; Eaton J.D.; Grassi A.; Potter M.; Shaw B.; Salat C.; Neumeister P.; Finazzi G.; Iacobelli M.; Bowyer K.; Prentice H.G.; Barbui T.

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
pp. 1130-1137(8)
Authors: Ringdén O.; Labopin M.; Gorin N.C.; Schmitz N.; Schaefer U.W.; Prentice H.G.; Bergmann L.; Jouet J.P.; Mandelli F.; Blaise D.; Fouillard L.; . Frassoni F.

The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens
pp. 1138-1144(7)
Authors: de Boer F.; Dräger A.M.; Van Haperen M.J.A.M.; van der Wall E.; Kessler F.; Huijgens P.C.; Pinedo H.M.; Schuurhuis G.J.

Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH₃
pp. 1145-1152(8)
Authors: Wierenga P.K.; Setroikromo R.; Vellenga E.; Kampinga H.H.

Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts
pp. 1153-1157(5)
Authors: Boulad F.; Gillio A.; Small T.N.; George D.; Prasad V.; Torok-Castanza J.; Regan A.D.; Collins N.; Auerbach A.D.; Kernan N.A.; O'reilly R.J.

PNH cells are as sensitive to T-cell-mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria
pp. 1158-1163(6)
Authors: Karadimitris A.; Notaro R.; Koehne G.; Roberts I.A.G.; Luzzatto L.

Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas–Fas-L interaction
pp. 1164-1169(6)
Authors: Killick S.B.; Cox C.V.; Marsh J.C.W.; Gordon-Smith E.C.; Gibson F.M.

Cytokine requirement for the development of T-lymphoid lineage potential in clonal lymphohaematopoietic progenitors in vitro
pp. 1170-1179(10)
Authors: Ma F.; Yang F-C.; Kaneko A.; Manabe A.; Tanaka R.; Asano S.; Nakahata T.; Tsuji K.

Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue-activating peptide CTAP III
pp. 1180-1189(10)
Authors: Deutsch V.; Bitan M.; Friedmann Y.; Eldor A.; Vlodavsky I.

A recurrent frameshift mutation of the ankyrin gene associated with severe hereditary spherocytosis
pp. 1190-1193(4)
Authors: Gallagher P.G.; Ferreira J.D.S.; Costa F.F.; Saad S.T.O.; Forget B.G.

Hypofibronectinaemia and severity of sickle cell anaemia in Nigeria
pp. 1194-1197(0)
Authors: Emeribe A.O.; Udoh A.E.; Etukudoh M.H.; Okany C.C.; Kehinde M.; Catty D.; Raykundalia C.

Affordable CD4⁺ T-cell counts on ‘single-platform’ flow cytometers I. Primary CD4 gating
pp. 1198-1208(11)
Authors: Janossy G.; Jani I.; Göhde W.

Age-dependent variations in the expression of PLC isoforms upon mitogenic stimulation of peripheral blood T cells from healthy donors
pp. 1209-1214(6)
Authors: Di Pietro R.; Miscia S.; Cataldi A.; Rana R.

von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura
pp. 1215-1222(8)
Authors: Allford S.L.; Harrison P.; Lawrie A.S.; Liesner R.; Mackie I.J.; Machin S.J.

The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both
pp. 1223-1229(7)
Authors: Martinelli I.; Bucciarelli P.; Margaglione M.; De Stefano V.; Castaman G.; Mannucci P.M.

The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant
pp. 1230-1235(6)
Authors: Gardiner C.; Mackie I.J.; Malia R.G.; Jones D.W.; Winter M.; Leeming D.; Taberner D.A.; Machin S.J.; Greaves M.

Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease
pp. 1236-1239(4)
Authors: Lak M.; Peyvandi F.; Mannucci P.M.

A novel two base pair deletion in the factor V gene associated with severe factor V deficiency
pp. 1240-1246(7)
Authors: Montefusco M.C.; Duga S.; Asselta R.; Santagostino E.; Mancuso G.; Malcovati M.; Mannucci P.M.; Tenchini M.L.

Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ib with human platelet antigen-2 and variable number of tandem repeats polymorphism, and its relationship with coronary artery disease
pp. 1247-1249(3)
Authors: Ishida F.; Ito T.; Takei M.; Shimodaira S.; Kitano K.; Kiyosawa K.

Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100
pp. 1250-1252(3)
Authors: Homoncik M.; Blann A.D.; Hollenstein U.; Pernerstorfer T.; Eichler H-G.; Jilma B.

A comparison of polymorphism in the 3-untranslated region of the prothrombin gene between Chinese and Caucasians in Australia
pp. 1253-1255(3)
Authors: Chan D.K.Y.; Hu G.; Tao H.; Owens D.; Vun C.M.; Woo J.; Chong B.H.

Identification of a new CA dinucleotide repeat in the human factor VIII gene
pp. 1256-1259(4)
Authors: Lin S-R.; Lin S-W.; Hsu Y-C.; Shen M-C.

DDAVP (desmopressin; 1-deamino-cys-8-d-arginine-vasopressin) treatment in children with haemophilia B
pp. 1260-1262(3)
Authors: Ehl S.; Severin T.; Sutor A.H.

Book Review
pp. 1263-1263(1)
Author: Marsh J.